vs
Alpha Metallurgical Resources, Inc.（AMR）与Astrana Health, Inc.（ASTH）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Alpha Metallurgical Resources, Inc.的1.8倍（$950.5M vs $519.1M），Astrana Health, Inc.净利率更高（0.7% vs -3.3%，领先4.0%），Astrana Health, Inc.同比增速更快（42.9% vs -15.7%），Astrana Health, Inc.自由现金流更多（$-6.0M vs $-10.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs -22.4%）
阿尔法冶金资源（前身为康图拉能源）是行业领先的煤炭供应商，在阿巴拉契亚北部和中部拥有地下及露天煤矿综合体，在宾夕法尼亚州、弗吉尼亚州和西弗吉尼亚州坐拥大型煤田，生产用于炼钢的冶金煤和用于发电的动力煤，供应全球下游客户。
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
AMR vs ASTH — 直观对比
营收规模更大
ASTH
是对方的1.8倍
$519.1M
营收增速更快
ASTH
高出58.5%
-15.7%
净利率更高
ASTH
高出4.0%
-3.3%
自由现金流更多
ASTH
多$4.0M
$-10.0M
两年增速更快
ASTH
近两年复合增速
-22.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $519.1M | $950.5M |
| 净利润 | $-17.3M | $6.6M |
| 毛利率 | — | — |
| 营业利润率 | -4.1% | 1.9% |
| 净利率 | -3.3% | 0.7% |
| 营收同比 | -15.7% | 42.9% |
| 净利润同比 | -711.2% | 184.4% |
| 每股收益（稀释后） | $-1.35 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRASTH
| Q4 25 | $519.1M | $950.5M | ||
| Q3 25 | $525.2M | $956.0M | ||
| Q2 25 | $548.7M | $654.8M | ||
| Q1 25 | $529.7M | $620.4M | ||
| Q4 24 | $615.4M | $665.2M | ||
| Q3 24 | $669.8M | $478.7M | ||
| Q2 24 | $800.1M | $486.3M | ||
| Q1 24 | $861.3M | $404.4M |
净利润AMRASTH
| Q4 25 | $-17.3M | $6.6M | ||
| Q3 25 | $-5.5M | $373.0K | ||
| Q2 25 | $-5.0M | $9.4M | ||
| Q1 25 | $-33.9M | $6.7M | ||
| Q4 24 | $-2.1M | $-7.8M | ||
| Q3 24 | $3.8M | $16.1M | ||
| Q2 24 | $58.9M | $19.2M | ||
| Q1 24 | $127.0M | $14.8M |
营业利润率AMRASTH
| Q4 25 | -4.1% | 1.9% | ||
| Q3 25 | -0.5% | 2.0% | ||
| Q2 25 | 0.5% | 3.1% | ||
| Q1 25 | -7.6% | 3.3% | ||
| Q4 24 | 1.6% | 0.1% | ||
| Q3 24 | 0.8% | 5.9% | ||
| Q2 24 | 8.8% | 6.2% | ||
| Q1 24 | 16.5% | 7.5% |
净利率AMRASTH
| Q4 25 | -3.3% | 0.7% | ||
| Q3 25 | -1.1% | 0.0% | ||
| Q2 25 | -0.9% | 1.4% | ||
| Q1 25 | -6.4% | 1.1% | ||
| Q4 24 | -0.3% | -1.2% | ||
| Q3 24 | 0.6% | 3.4% | ||
| Q2 24 | 7.4% | 3.9% | ||
| Q1 24 | 14.7% | 3.7% |
每股收益（稀释后）AMRASTH
| Q4 25 | $-1.35 | $0.12 | ||
| Q3 25 | $-0.42 | $0.01 | ||
| Q2 25 | $-0.38 | $0.19 | ||
| Q1 25 | $-2.60 | $0.14 | ||
| Q4 24 | $-0.09 | $-0.14 | ||
| Q3 24 | $0.29 | $0.33 | ||
| Q2 24 | $4.49 | $0.40 | ||
| Q1 24 | $9.59 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $415.6M | $429.5M |
| 总债务越低越好 | $9.8M | — |
| 股东权益账面价值 | $1.5B | $779.3M |
| 总资产 | $2.3B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势，按日历期对齐
现金及短期投资AMRASTH
| Q4 25 | $415.6M | $429.5M | ||
| Q3 25 | $457.9M | $463.4M | ||
| Q2 25 | $449.0M | $342.1M | ||
| Q1 25 | $448.0M | $260.9M | ||
| Q4 24 | $481.6M | $290.8M | ||
| Q3 24 | $484.6M | $350.3M | ||
| Q2 24 | $336.1M | $327.7M | ||
| Q1 24 | $269.4M | $337.3M |
总债务AMRASTH
| Q4 25 | $9.8M | — | ||
| Q3 25 | $2.9M | — | ||
| Q2 25 | $3.1M | — | ||
| Q1 25 | $2.4M | — | ||
| Q4 24 | $2.9M | — | ||
| Q3 24 | $3.6M | — | ||
| Q2 24 | $5.3M | — | ||
| Q1 24 | $6.0M | — |
股东权益AMRASTH
| Q4 25 | $1.5B | $779.3M | ||
| Q3 25 | $1.6B | $775.5M | ||
| Q2 25 | $1.6B | $765.5M | ||
| Q1 25 | $1.6B | $745.4M | ||
| Q4 24 | $1.6B | $712.7M | ||
| Q3 24 | $1.7B | $704.6M | ||
| Q2 24 | $1.6B | $678.9M | ||
| Q1 24 | $1.6B | $653.5M |
总资产AMRASTH
| Q4 25 | $2.3B | $2.2B | ||
| Q3 25 | $2.3B | $2.2B | ||
| Q2 25 | $2.4B | $1.4B | ||
| Q1 25 | $2.4B | $1.3B | ||
| Q4 24 | $2.4B | $1.4B | ||
| Q3 24 | $2.5B | $1.3B | ||
| Q2 24 | $2.5B | $1.3B | ||
| Q1 24 | $2.5B | $1.2B |
负债/权益比AMRASTH
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.0M | $-2.9M |
| 自由现金流经营现金流 - 资本支出 | $-10.0M | $-6.0M |
| 自由现金流率自由现金流/营收 | -1.9% | -0.6% |
| 资本支出强度资本支出/营收 | 5.6% | 0.3% |
| 现金转化率经营现金流/净利润 | — | -0.44× |
| 过去12个月自由现金流最近4个季度 | $17.8M | $104.5M |
8季度趋势，按日历期对齐
经营现金流AMRASTH
| Q4 25 | $19.0M | $-2.9M | ||
| Q3 25 | $50.5M | $10.0M | ||
| Q2 25 | $53.2M | $90.9M | ||
| Q1 25 | $22.2M | $16.6M | ||
| Q4 24 | $56.3M | $-10.9M | ||
| Q3 24 | $189.5M | $34.0M | ||
| Q2 24 | $138.1M | $23.2M | ||
| Q1 24 | $196.1M | $6.0M |
自由现金流AMRASTH
| Q4 25 | $-10.0M | $-6.0M | ||
| Q3 25 | $25.4M | $7.4M | ||
| Q2 25 | $18.6M | $89.5M | ||
| Q1 25 | $-16.3M | $13.6M | ||
| Q4 24 | $13.6M | $-13.5M | ||
| Q3 24 | $158.0M | $31.7M | ||
| Q2 24 | $77.0M | $20.4M | ||
| Q1 24 | $132.5M | $5.6M |
自由现金流率AMRASTH
| Q4 25 | -1.9% | -0.6% | ||
| Q3 25 | 4.8% | 0.8% | ||
| Q2 25 | 3.4% | 13.7% | ||
| Q1 25 | -3.1% | 2.2% | ||
| Q4 24 | 2.2% | -2.0% | ||
| Q3 24 | 23.6% | 6.6% | ||
| Q2 24 | 9.6% | 4.2% | ||
| Q1 24 | 15.4% | 1.4% |
资本支出强度AMRASTH
| Q4 25 | 5.6% | 0.3% | ||
| Q3 25 | 4.8% | 0.3% | ||
| Q2 25 | 6.3% | 0.2% | ||
| Q1 25 | 7.3% | 0.5% | ||
| Q4 24 | 6.9% | 0.4% | ||
| Q3 24 | 4.7% | 0.5% | ||
| Q2 24 | 7.6% | 0.6% | ||
| Q1 24 | 7.4% | 0.1% |
现金转化率AMRASTH
| Q4 25 | — | -0.44× | ||
| Q3 25 | — | 26.69× | ||
| Q2 25 | — | 9.65× | ||
| Q1 25 | — | 2.48× | ||
| Q4 24 | — | — | ||
| Q3 24 | 49.81× | 2.11× | ||
| Q2 24 | 2.34× | 1.21× | ||
| Q1 24 | 1.54× | 0.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMR
暂无分部数据
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
